nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A call to optimize haemodialysis vascular access care in healthcare disrupted by COVID-19 pandemic
|
Basile, Carlo |
|
|
34 |
2 |
p. 365-368 |
artikel |
2 |
Acute kidney injury and mortality risk in older adults with COVID-19
|
Xu, Hong |
|
|
34 |
2 |
p. 295-304 |
artikel |
3 |
A sad anniversary, one year of COVID-19 epidemics—in this issue: from COVID-19 to membranous nephropathy
|
Piccoli, Giorgina B. |
|
|
34 |
2 |
p. 273-275 |
artikel |
4 |
Association between nonsteroidal anti-inflammatory drug use and major adverse cardiovascular events in patients with end-stage renal disease: a population-based cohort study
|
Liao, Yu-Chen |
|
|
34 |
2 |
p. 441-449 |
artikel |
5 |
Association of kidney transplantation with mortality on hemodialysis after graft failure
|
Kawaguchi, Takehiko |
|
|
34 |
2 |
p. 521-530 |
artikel |
6 |
Calcineurin inhibitors in lupus nephritis
|
Ponticelli, Claudio |
|
|
34 |
2 |
p. 399-402 |
artikel |
7 |
Clinical significance of glomerular C3 deposition in primary membranous nephropathy
|
Oto, Ozgur Akin |
|
|
34 |
2 |
p. 581-587 |
artikel |
8 |
Correction to: COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist
|
Laboux, Timothée |
|
|
34 |
2 |
p. 379 |
artikel |
9 |
COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist
|
Laboux, Timothée |
|
|
34 |
2 |
p. 373-378 |
artikel |
10 |
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
|
Porcelli, Brunetta |
|
|
34 |
2 |
p. 573-579 |
artikel |
11 |
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy
|
Fenoglio, Roberta |
|
|
34 |
2 |
p. 565-571 |
artikel |
12 |
Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study.
|
Bussalino, Elisabetta |
|
|
34 |
2 |
p. 531-538 |
artikel |
13 |
Far di Necessità Virtù, using rare tubulopathies, Gitelman’s and Bartter’s syndromes, to inform the fight against COVID-19
|
Calò, Lorenzo A. |
|
|
34 |
2 |
p. 281-283 |
artikel |
14 |
Feasibility of computed tomography-based assessment of skeletal muscle mass in hemodialysis patients
|
Takata, Tomoaki |
|
|
34 |
2 |
p. 465-471 |
artikel |
15 |
From tuberous sclerosis complex to end stage renal disease: who are these patients?
|
Vabret, Elsa |
|
|
34 |
2 |
p. 607-615 |
artikel |
16 |
Hand function assessment in peritoneal dialysis patient: a pilot study
|
Beaumier, Mathilde |
|
|
34 |
2 |
p. 483-491 |
artikel |
17 |
Identical twins with idiopathic membranous nephropathy
|
Tao, Tian |
|
|
34 |
2 |
p. 597-601 |
artikel |
18 |
Identifying prognostic risk factors for poor outcome following COVID-19 disease among in-centre haemodialysis patients: role of inflammation and frailty
|
Hendra, Heidy |
|
|
34 |
2 |
p. 315-323 |
artikel |
19 |
Immunosuppression-related neurological disorders in kidney transplantation
|
Faravelli, Irene |
|
|
34 |
2 |
p. 539-555 |
artikel |
20 |
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients
|
Bolignano, Davide |
|
|
34 |
2 |
p. 451-458 |
artikel |
21 |
Lesson for the clinical nephrologist: Kidney transplant, COVID-19 and pregnancy
|
Gleeson, Sarah |
|
|
34 |
2 |
p. 369-371 |
artikel |
22 |
Living Well with Kidney Disease by patient and care-partner empowerment: Kidney Health for Everyone Everywhere
|
Kalantar-Zadeh, Kamyar |
|
|
34 |
2 |
p. 381-388 |
artikel |
23 |
Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases
|
Wang, Ren |
|
|
34 |
2 |
p. 589-596 |
artikel |
24 |
Lower serum bicarbonate is associated with an increased risk of acute kidney injury
|
Kendrick, Jessica |
|
|
34 |
2 |
p. 433-439 |
artikel |
25 |
Membranous nephropathy: setting the bar for hypothesis-driven, selective therapies in nephrology
|
Angeletti, Andrea |
|
|
34 |
2 |
p. 561-563 |
artikel |
26 |
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up
|
Argolini, Lorenza Maria |
|
|
34 |
2 |
p. 389-398 |
artikel |
27 |
Proteinuria in COVID-19: prevalence, characterization and prognostic role
|
Huart, Justine |
|
|
34 |
2 |
p. 355-364 |
artikel |
28 |
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey
|
Nordio, Maurizio |
|
|
34 |
2 |
p. 325-335 |
artikel |
29 |
Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection
|
Lanzani, Chiara |
|
|
34 |
2 |
p. 305-314 |
artikel |
30 |
SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience
|
Rombolà, Giuseppe |
|
|
34 |
2 |
p. 277-279 |
artikel |
31 |
Serum β2-microglobulin as a predictor of residual kidney function in peritoneal dialysis patients
|
Jaques, David A. |
|
|
34 |
2 |
p. 473-481 |
artikel |
32 |
Severe acute kidney injury in critically ill COVID-19 patients
|
Piñeiro, Gaston J. |
|
|
34 |
2 |
p. 285-293 |
artikel |
33 |
Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab
|
Schmidt, Tilman |
|
|
34 |
2 |
p. 603-606 |
artikel |
34 |
Systemic sclerosis and end-stage renal disease: study of patient characteristics, follow-up and outcomes in France
|
Lavergne, Aurélie |
|
|
34 |
2 |
p. 617-625 |
artikel |
35 |
Targeting COVID-19 prevention in hemodialysis facilities is associated with a drastic reduction in central venous catheter-related infections
|
Heidempergher, Marco |
|
|
34 |
2 |
p. 345-353 |
artikel |
36 |
The Impact of COVID-19 on the mental health of dialysis patients
|
Bonenkamp, Anna A. |
|
|
34 |
2 |
p. 337-344 |
artikel |
37 |
The impact of the superficial cuff position on the exit site and tunnel infections in CAPD patients
|
Nardelli, Luca |
|
|
34 |
2 |
p. 493-501 |
artikel |
38 |
The lacking equation that estimates the protein catabolic rate in patients on once-weekly haemodialysis
|
Casino, Francesco Gaetano |
|
|
34 |
2 |
p. 459-464 |
artikel |
39 |
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis
|
Bonomini, Mario |
|
|
34 |
2 |
p. 503-519 |
artikel |
40 |
The relationship between intra-parenchymal renal resistive index variation and renal functional reserve in healthy subjects
|
Samoni, Sara |
|
|
34 |
2 |
p. 403-409 |
artikel |
41 |
Towards optimizing use of PLA2R antibody testing in membranous nephropathy
|
Hogan, Jonathan J. |
|
|
34 |
2 |
p. 557-559 |
artikel |
42 |
Urinary strips for protein assays: easy to do but difficult to interpret!
|
Résimont, Guillaume |
|
|
34 |
2 |
p. 411-432 |
artikel |